The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Discover why the divisor method is favored for benchmarks, offering continuity, fairness, and easier comparison across periods and actions.
22,124 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A caller in his 60s with a six-figure income and no retirement savings since 2008 receives a blunt reality check on T...
New research finds CFOs overseeing AI projects unlock significantly more value, with 76% reporting strong gains when ...
When homes linger on the market, buyers gain negotiating power and lenders adjust terms. This guide explains how stal...
The Invesco PDBC ETF jumped higher as crude oil rallied to the 98th percentile of its five-year range, highlighting t...
Clark Howard weighs in on helping a family member build credit without jeopardizing your own score, after a May 11, 2...
When a fund trims its Planet Fitness position, it sends a message about risk, growth, and the path for 2026. This dee...
SCHD has surged in 2026, outpacing the S&P 500 as dividend-growth funds draw cash-flow hungry investors. Three core E...
As AI-driven demand accelerates, the real trade sits with the equipment suppliers that power chip production. ASML, A...
A 25-year-old with $150,000 saved faces a high-stakes choice: wipe out debt now or hold cash and risk higher costs la...
Strategy stock essentially leveraged means the company borrows to buy Bitcoin, making its fate closely tied to crypto...
ETHA’s Spot Ethereum Promise meets a built-in constraint: the iShares Ethereum Trust cannot pass through staking rewa...